Skip to content

Study on the Precision of TCM diagnosis and treatment of uterine adenomyosis dysmenorrhea: a randomized controlled trial.

Study on the Precision of TCM diagnosis and treatment of uterine adenomyosis dysmenorrhea

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003736
Enrollment
Unknown
Registered
2020-08-26
Start date
2020-10-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenomyosis

Interventions

Sponsors

Yueyang Integrative Medicine Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: (1) It conforms to the diagnostic standard of Western medicine and dialectical standard of TCM syndromes. (2) Women aged 18-45 years old. (3) Agree to participate in clinical trial observation, sign informed consent and cooperate with random visitors.

Exclusion criteria

Exclusion criteria: (1) Pelvic pain caused by adnexitis or endometriosis; Tuberculous nodules of internal reproductive tract. (2) Patients with cardiovascular, cerebrovascular, liver, kidney, hematopoietic system and other serious diseases, as well as those with a history of mental disorders and family history. (3) pregnancy and lactation. (4) people with a history of severe drug allergy. (5) those who take hormone drugs and stop taking them for less than 3 months.

Design outcomes

Primary

MeasureTime frame
Dysmenorrhea symptom score;7/5000 GAD - 7 scale;PBAC score for menstrual volume;visual analogue scale, VAS;TCM syndrome Rating Scale;

Secondary

MeasureTime frame
The humoral immune;HE4;Platelet aggregation;Cellular immune;CA125;prostaglandin;cytokines;

Countries

China

Contacts

Public ContactZhangTingting

Study on the Precision of TCM diagnosis and treatment of uterine adenomyosis dysmenorrhea

tingting185@aliyun.com+86 13671600698

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026